Lipocine logo

Lipocine Share Price (NASDAQ: LPCN)

Market is closed - opens 7 PM IST, 04 Aug 2025

$3.15

-0.08

(-2.48%)

Last updated on 02 Aug 2025, 01:27 AM IST

Check the interactive Lipocine Stock chart to analyse performance

Lipocine stock performance

as on 02 Aug 2025, 01:27 AM IST

  • Today's Low: $3.15
    Today's High: $3.20

    Day's Volatility :1.56%

  • 52 Weeks Low: $2.68
    52 Weeks High: $6.17

    52 Weeks Volatility :56.49%

Lipocine Stock Returns

PeriodLipocine IncIndex (Russel 2000)
3 Months
-7.31%
0.0%
6 Months
-27.29%
0.0%
1 Year
-36.09%
0.0%
3 Years
-76.82%
-6.0%

Lipocine Inc Key Stats

Check Lipocine key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$3.23
Open
$3.2
Today's High
$3.2
Today's Low
$3.15
Market Capitalization
$17.3M
Today's Volume
$21.6K
52 Week High
$6.1683
52 Week Low
$2.6838
Revenue TTM
$3.7M
EBITDA
$-6.4M
Earnings Per Share (EPS)
$-1.01
Profit Margin
-146.13%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-24.89%

Stock Returns calculator for Lipocine Stock including INR - Dollar returns

The Lipocine stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Lipocine investment value today

Current value as on today

₹67,921

Returns

₹32,079

(-32.08%)

Returns from Lipocine Stock

₹36,492 (-36.49%)

Dollar Returns*

₹4,413 (+4.41%)

Indian investors sentiment towards Lipocine Stock

57%

Period: Jul 2, 2025 to Aug 1, 2025. Change in 30 Days versus previous period

Search interest for Lipocine Stock from India on INDmoney has increased by 57% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Lipocine Inc

  • Name

    Holdings %

  • Vanguard Group Inc

    4.23%

  • BlackRock Inc

    1.67%

  • Geode Capital Management, LLC

    1.10%

  • Susquehanna International Group, LLP

    0.73%

  • Renaissance Technologies Corp

    0.70%

  • Dimensional Fund Advisors, Inc.

    0.47%

Analyst Recommendation on Lipocine Stock

Rating
Trend

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Lipocine(by analysts ranked 0 to 5 stars)

Lipocine Share Price Target

What analysts predicted

Upside of 134.13%

Target:

$7.38

Current:

$3.15

Lipocine share price target is $7.38, a slight Upside of 134.13% compared to current price of $3.15 as per analysts' prediction.

Lipocine Stock Insights

  • Price Movement

    In the last 1 year, LPCN stock has moved down by -34.1%
  • LPCN vs ONC (1 yr)

    In the last 1 year, Beone Medicines Ltd has given 84.2% return, outperforming this stock by 118.3%
  • LPCN vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 81.3% return, outperforming this stock by 157.0%
  • Price to Sales

    ForLPCN every $1 of sales, investors are willing to pay $4.6, whereas for Beone Medicines Ltd, the investors are paying $7.6 for every $1 of sales.

Lipocine Technicals Summary

Sell

Neutral

Buy

Lipocine is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Lipocine Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Lipocine Inc logo
2.26%
-27.29%
-36.09%
-76.82%
-89.1%
Regeneron Pharmaceuticals, Inc. logo
-0.36%
-16.51%
-48.55%
-8.54%
-13.7%
Beone Medicines Ltd logo
22.47%
33.89%
83.22%
76.22%
34.92%
Vertex Pharmaceuticals Incorporated logo
-0.64%
-1.72%
-6.51%
68.08%
65.38%
Alnylam Pharmaceuticals, Inc. logo
18.03%
46.25%
47.6%
89.4%
163.65%

About Lipocine Inc

Lipocine Inc., a clinical-stage biopharmaceutical company, engages in the research and development for the delivery of drugs for the treatment of central nervous system (CNS) disorders. Its lead product candidate is TLANDO, an oral testosterone replacement therapy (TRT) comprising testosterone undecanoate. The company's pipeline candidates also include LPCN 1111 (TLANDO XR), a next-generation long-acting oral product candidate for TRT; LPCN 1148, a novel prodrug of testosterone and testosterone laurate for the treatment of cirrhosis; LPCN 1154 to treat postpartum depression; LPCN 2101, a NAS candidate for women with epilepsy; and LPCN 2203, an oral candidate for management of essential tremor. It also develops LPCN 1144, an oral prodrug of bioidentical testosterone for the treatment of metabolic dysfunction-associated steatohepatitis; LPCN 2401 to improve body composition in obesity management; and LPCN 1107, an oral hydroxy progesterone caproate product indicated for the prevention of recurrent preterm birth. The company was founded in 1997 and is headquartered in Salt Lake City, Utah.
Organization
Lipocine
Employees
16
CEO
Dr. Mahesh V. Patel Ph.D.
Industry
Health Technology

Key Management of Lipocine Inc

NameTitle
Dr. Mahesh V. Patel Ph.D.
Co-Founder, Interim Principal Financial Officer, Director, President & CEO
Ms. Krista Fogarty
Principal Accounting Officer & Corporate Controller
Dr. Nachiappan Chidambaram Ph.D.
Senior Vice President of Research & Development
Mr. Logan Morse
Vice President of Sales, Marketing & Operations
Dr. Anthony DelConte M. D., M.D.
Chief Medical Director

Important FAQs about investing in LPCN Stock from India :

How to invest in Lipocine Stock (LPCN) from India?

It is very easy for Indian residents to invest directly in Lipocine from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Lipocine stock in both Indian Rupees (INR) and US Dollars (USD). Search for Lipocine or LPCN on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Lipocine or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Lipocine shares which would translate to 0.278 fractional shares of Lipocine as of today. Learn more about fractional investing.

Can Indians buy Lipocine shares?

Yes, Indians can invest in the Lipocine (LPCN) from India.

With INDmoney, you can buy Lipocine at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Lipocine at zero transaction cost.

How can I buy Lipocine shares from India?

It is very easy to buy Lipocine from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Lipocine (LPCN) be purchased?

Yes, you can buy fractional shares of Lipocine with INDmoney app.

What are the documents required to start investing in Lipocine stocks?

To start investing in Lipocine, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is Lipocine share price today?

Lipocine share price today stands at $3.15, Open: $3.20 ; Previous Close: $3.23 ; High: $3.20 ; Low: $3.15 ; 52 Week High: $6.17 ; 52 Week Low: $2.68.

The stock opens at $3.20, after a closing price of $3.23. The stock reached a daily high of $3.20 and a low of $3.15, with a 52-week high of $6.17 and a 52-week low of $2.68.

What are today’s High and Low prices of Lipocine Stock (LPCN)?

Today’s highest price of Lipocine (LPCN) is $3.20.

Today’s lowest price of Lipocine (LPCN) is $3.15.

What is the 52 Week High and Low Range of Lipocine Stock (LPCN)?

  • 52 Week High

    $6.17

  • 52 Week Low

    $2.68

What are the historical returns of Lipocine (LPCN)?

  • 1 Month Returns

    2.26%

  • 3 Months Returns

    -27.29%

  • 1 Year Returns

    -36.09%

  • 5 Years Returns

    -89.1%

What is today's market capitalisation of Lipocine?

Today's market capitalisation of Lipocine LPCN is 17.3M

Who is the Chief Executive Officer (CEO) of Lipocine ?

Dr. Mahesh V. Patel Ph.D. is the current Chief Executive Officer (CEO) of Lipocine.